ZA200404929B - Test strip for determining concentration of multiple analytes in a single fluid sample - Google Patents
Test strip for determining concentration of multiple analytes in a single fluid sample Download PDFInfo
- Publication number
- ZA200404929B ZA200404929B ZA200404929A ZA200404929A ZA200404929B ZA 200404929 B ZA200404929 B ZA 200404929B ZA 200404929 A ZA200404929 A ZA 200404929A ZA 200404929 A ZA200404929 A ZA 200404929A ZA 200404929 B ZA200404929 B ZA 200404929B
- Authority
- ZA
- South Africa
- Prior art keywords
- layer
- stacks
- blood
- sample
- test strip
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 113
- 239000012530 fluid Substances 0.000 title description 26
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 108
- 210000004369 blood Anatomy 0.000 claims abstract description 97
- 239000008280 blood Substances 0.000 claims abstract description 97
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 56
- 239000011159 matrix material Substances 0.000 claims abstract description 54
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 19
- 239000008103 glucose Substances 0.000 claims abstract description 19
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 8
- 150000002576 ketones Chemical class 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 22
- 239000003365 glass fiber Substances 0.000 claims description 14
- 210000003743 erythrocyte Anatomy 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 238000005194 fractionation Methods 0.000 claims description 9
- 230000007480 spreading Effects 0.000 claims description 8
- 238000003892 spreading Methods 0.000 claims description 8
- 238000008214 LDL Cholesterol Methods 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 2
- 108010023302 HDL Cholesterol Proteins 0.000 abstract description 7
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 239000010410 layer Substances 0.000 description 229
- 108010010234 HDL Lipoproteins Proteins 0.000 description 53
- 102000015779 HDL Lipoproteins Human genes 0.000 description 53
- 239000000243 solution Substances 0.000 description 29
- 238000005470 impregnation Methods 0.000 description 26
- 239000012528 membrane Substances 0.000 description 23
- 210000002381 plasma Anatomy 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000008367 deionised water Substances 0.000 description 18
- 229910021641 deionized water Inorganic materials 0.000 description 18
- 108010007622 LDL Lipoproteins Proteins 0.000 description 12
- 102000007330 LDL Lipoproteins Human genes 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 8
- 210000000601 blood cell Anatomy 0.000 description 7
- 238000007664 blowing Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 6
- 239000012491 analyte Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000013508 migration Methods 0.000 description 5
- 230000005012 migration Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000005693 optoelectronics Effects 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 241001191009 Gymnomyza Species 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- HLXGRHNZZSMNRX-UHFFFAOYSA-M sodium;3-(n-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 HLXGRHNZZSMNRX-UHFFFAOYSA-M 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 108010004103 Chylomicrons Proteins 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 150000001841 cholesterols Chemical class 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 description 1
- 108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000057621 Glycerol kinases Human genes 0.000 description 1
- 108700016170 Glycerol kinases Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- XMEKHKCRNHDFOW-UHFFFAOYSA-N O.O.[Na].[Na] Chemical compound O.O.[Na].[Na] XMEKHKCRNHDFOW-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 108010069201 VLDL Cholesterol Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- -1 i.e. Proteins 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- RQVZIJIQDCGIKI-UHFFFAOYSA-M sodium;oxamate Chemical compound [Na+].NC(=O)C([O-])=O RQVZIJIQDCGIKI-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34430001P | 2001-12-28 | 2001-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200404929B true ZA200404929B (en) | 2006-10-25 |
Family
ID=23349931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200404929A ZA200404929B (en) | 2001-12-28 | 2002-12-30 | Test strip for determining concentration of multiple analytes in a single fluid sample |
Country Status (9)
Country | Link |
---|---|
US (3) | US7214504B2 (de) |
EP (2) | EP1474692B1 (de) |
AT (1) | ATE386266T1 (de) |
AU (2) | AU2002359891A1 (de) |
CA (1) | CA2471726C (de) |
DE (1) | DE60225058T2 (de) |
MX (1) | MXPA04006367A (de) |
WO (2) | WO2003058239A2 (de) |
ZA (1) | ZA200404929B (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1334349B1 (de) * | 2000-10-18 | 2012-03-07 | Art & Science, Inc. | Verfahren zum verdünnen einer flüssigkeit und zum erkennen von analyten in einer verdünnten flüssigkeit |
AU2002305631B2 (en) * | 2001-05-17 | 2007-01-04 | Cook Medical Technologies Llc | Intragastric device for treating obesity |
AU2002359891A1 (en) * | 2001-12-28 | 2003-07-24 | Polymer Technology Systems, Inc. | Test strip for determining concentration of triglycerides |
JP4283512B2 (ja) * | 2002-09-09 | 2009-06-24 | アークレイ株式会社 | 試験用具、およびそれの製造方法 |
US8722417B2 (en) | 2003-04-28 | 2014-05-13 | Invoy Technologies, L.L.C. | Thermoelectric sensor for analytes in a fluid and related method |
US8088333B2 (en) * | 2003-04-28 | 2012-01-03 | Invoy Technology, LLC | Thermoelectric sensor for analytes in a gas |
EP1627218A2 (de) * | 2003-04-28 | 2006-02-22 | Arizona Board of Regents, acting for and on behalf of, Arizona State University | Thermoelektrischer biosensor für analyten in einem gas |
US7625721B2 (en) | 2004-02-03 | 2009-12-01 | Polymer Technology Systems, Inc. | Non-precipitating bodily fluid analysis system |
US20060062688A1 (en) * | 2004-02-03 | 2006-03-23 | Polymer Technology Systems, Inc. | Bodily fluid analysis system |
US7435577B2 (en) | 2004-02-03 | 2008-10-14 | Polymer Technology Systems, Inc. | Direct measurement of chlolesterol from low density lipoprotein with test strip |
US8465696B2 (en) | 2004-02-03 | 2013-06-18 | Polymer Technology Systems, Inc. | Dry test strip with controlled flow and method of manufacturing same |
US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
US20060062690A1 (en) * | 2004-08-17 | 2006-03-23 | Polymer Technology Systems, Inc. | Apparatus and method of manufacturing bodily fluid test strip |
GB0428130D0 (en) * | 2004-12-22 | 2005-01-26 | Oxford Biosensors Ltd | Selective HDL cholesterol assay |
EP1949102A2 (de) * | 2005-11-15 | 2008-07-30 | Inverness Medical Switzerland GmbH | Testverfahren |
GB0526051D0 (en) * | 2005-12-21 | 2006-02-01 | Oxford Biosensors Ltd | Cholesterol sensor |
US20070179373A1 (en) * | 2005-12-22 | 2007-08-02 | Provex Technologies, Llc. | Integrated patch and assay device with visual detection means |
GB2435510A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Enzyme detection product and methods |
GB2435512A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | A binding assay and assay device |
GB2435511A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Protease detection |
AU2015202260B9 (en) * | 2007-05-17 | 2017-03-02 | Advance Dx, Inc. | Method of processing a fluid sample using a fluid separator multi-layer device |
DE202009018896U1 (de) * | 2008-03-21 | 2014-05-02 | Eppendorf Ag | Küvette, Einsatz, Adapter zur optischen Untersuchung kleiner Flüssigkeitsmengen |
US9395373B2 (en) | 2008-06-13 | 2016-07-19 | Polymer Technology Systems, Inc. | Hybrid strip |
WO2009152373A1 (en) * | 2008-06-13 | 2009-12-17 | Polymer Technology Systems, Inc. | Hybrid strip |
WO2009155339A1 (en) * | 2008-06-17 | 2009-12-23 | Polymer Technology Systems, Inc. | System and method for packaging dry test strips |
CN102317773B (zh) | 2009-01-23 | 2015-03-11 | 聚合物技术系统公司 | 具有一体生物传感器的诊断式多层干相测试条 |
KR101110561B1 (ko) * | 2009-06-04 | 2012-02-15 | 주식회사 인포피아 | 바이오 센서 |
US20110048972A1 (en) * | 2009-08-31 | 2011-03-03 | Lifescan Scotland Limited | Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration |
WO2011048200A2 (de) * | 2009-10-22 | 2011-04-28 | Roche Diagnostics Gmbh | Mikrokapillarsystem mit erhöhtem probenvolumen |
US8632664B2 (en) * | 2009-10-27 | 2014-01-21 | Lifescan Scotland Limited | Test meter for use with a dual chamber, multi-analyte test strip with opposing electrodes |
US8323467B2 (en) * | 2009-10-27 | 2012-12-04 | Lifescan Scotland Limited | Dual chamber, multi-analyte test strip with opposing electrodes |
KR101271022B1 (ko) * | 2009-11-24 | 2013-06-04 | 주식회사 인포피아 | 다공성 필름이 부착되어 있는 멤브레인 바이오센서 및 이를 이용한 면역반응 또는 효소반응 측정방법 |
KR101198111B1 (ko) | 2011-05-31 | 2012-11-09 | 에스디 바이오센서 주식회사 | 센서스트립 |
US9857363B2 (en) | 2011-10-06 | 2018-01-02 | Ingibio, Ltd. | Membrane sensor capable of sequentially changing reaction condition by single sample injection |
EP3029463A1 (de) * | 2011-11-30 | 2016-06-08 | DiagnosTear Ltd | Trockenes-auge-diagnostik |
TWI456199B (zh) | 2011-12-29 | 2014-10-11 | Univ Nat Chiao Tung | 生物檢測裝置及檢測方法 |
ES2672268T3 (es) | 2012-01-10 | 2018-06-13 | Idexx Laboratories, Inc. | Portaobjetos para pruebas de inmunoanálisis |
CN102680672B (zh) * | 2012-05-08 | 2015-02-11 | 艾康生物技术(杭州)有限公司 | 检测装置 |
GB201403790D0 (en) * | 2014-03-04 | 2014-04-16 | Ge Healthcare Ltd | Microfluidic devices and arrangements for introducing reagents and biological samples to such devices |
WO2016086146A1 (en) * | 2014-11-25 | 2016-06-02 | Polymer Technology Systems, Inc. | Systems and methods for hematocrit correction in analyte test strips |
US20160313358A1 (en) * | 2015-04-23 | 2016-10-27 | Ted Titmus | Diagnostic test strips for detection of pre-specified blood alcohol levels |
WO2016178083A2 (en) | 2015-05-01 | 2016-11-10 | Diagnostear, Ltd. | Method for measuring tear constitutents in a tear sample |
US10132803B2 (en) | 2015-08-07 | 2018-11-20 | Xerox Corporation | Sulfonated polyester-metal nanoparticle composite toner for colorimetric sensing applications |
US11338294B2 (en) | 2017-04-27 | 2022-05-24 | Polybiomics, Inc. | Orthogonal polybiosensing and imaging systems |
CN107064484A (zh) * | 2017-05-25 | 2017-08-18 | 杭州博旭生物技术有限公司 | 自吸式干式生化检测装置 |
CN112924446A (zh) * | 2021-01-29 | 2021-06-08 | 苏州国科华睿生物医学工程技术有限公司 | 一种用于干式化学检测的试纸条承载板、试纸盒、分析仪 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283491A (en) * | 1977-09-06 | 1981-08-11 | Eastman Kodak Company | Analytical elements with improved reagent stability |
US4816224A (en) | 1980-08-05 | 1989-03-28 | Boehringer Mannheim Gmbh | Device for separating plasma or serum from whole blood and analyzing the same |
JP2647684B2 (ja) * | 1988-04-15 | 1997-08-27 | 旭化成工業株式会社 | トリグリセリドの分析用試薬および分析方法 |
JP2693786B2 (ja) * | 1988-08-09 | 1997-12-24 | ユニチカ株式会社 | 耐熱性のリポプロテインリパーゼとその製造法及びそれを用いた定量用試薬 |
US5156954A (en) * | 1989-03-08 | 1992-10-20 | Cholestech Corporation | Assay device and method using a signal-modulating compound |
US5135716A (en) * | 1989-07-12 | 1992-08-04 | Kingston Diagnostics, L.P. | Direct measurement of HDL cholesterol via dry chemistry strips |
DE3929032C2 (de) | 1989-09-01 | 1998-09-03 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt |
US5213964A (en) | 1990-07-16 | 1993-05-25 | Cholestech Corporation | High-density lipoprotein solid-base precipitation assay method |
US5213965A (en) * | 1990-07-16 | 1993-05-25 | Cholestech Corporation | Solid-phase precipitation assay device |
US5637469A (en) * | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
US5597532A (en) | 1994-10-20 | 1997-01-28 | Connolly; James | Apparatus for determining substances contained in a body fluid |
US5962215A (en) * | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
US6524864B2 (en) * | 2000-12-28 | 2003-02-25 | Aurora L. Fernandez Decastro | Test strip for simultaneous detection of a plurality of analytes |
US6844149B2 (en) * | 2001-06-29 | 2005-01-18 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
EP1495335A2 (de) * | 2001-12-21 | 2005-01-12 | Polymer Technology Systems, Inc. | Teststreifen und verfahren um hdl-cholesterin im vollblut oder plasma zu bestimmen |
AU2002359891A1 (en) * | 2001-12-28 | 2003-07-24 | Polymer Technology Systems, Inc. | Test strip for determining concentration of triglycerides |
-
2002
- 2002-12-30 AU AU2002359891A patent/AU2002359891A1/en not_active Abandoned
- 2002-12-30 US US10/334,044 patent/US7214504B2/en not_active Expired - Fee Related
- 2002-12-30 MX MXPA04006367A patent/MXPA04006367A/es active IP Right Grant
- 2002-12-30 ZA ZA200404929A patent/ZA200404929B/en unknown
- 2002-12-30 AT AT02794458T patent/ATE386266T1/de active
- 2002-12-30 WO PCT/US2002/041811 patent/WO2003058239A2/en active IP Right Grant
- 2002-12-30 CA CA2471726A patent/CA2471726C/en not_active Expired - Fee Related
- 2002-12-30 WO PCT/US2002/041672 patent/WO2003058252A2/en not_active Application Discontinuation
- 2002-12-30 EP EP02799993.7A patent/EP1474692B1/de not_active Expired - Lifetime
- 2002-12-30 DE DE60225058T patent/DE60225058T2/de not_active Expired - Lifetime
- 2002-12-30 EP EP02794458A patent/EP1459064B1/de not_active Expired - Lifetime
- 2002-12-30 US US10/334,043 patent/US7494818B1/en active Active
- 2002-12-30 AU AU2002364609A patent/AU2002364609B2/en not_active Ceased
-
2004
- 2004-06-22 US US10/873,415 patent/US7374719B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1474692B1 (de) | 2014-12-17 |
WO2003058252A3 (en) | 2004-08-05 |
AU2002359891A1 (en) | 2003-07-24 |
AU2002364609B2 (en) | 2008-04-03 |
CA2471726A1 (en) | 2003-07-17 |
US20050003523A1 (en) | 2005-01-06 |
WO2003058239A2 (en) | 2003-07-17 |
WO2003058252A2 (en) | 2003-07-17 |
EP1459064B1 (de) | 2008-02-13 |
WO2003058239A3 (en) | 2004-03-04 |
ATE386266T1 (de) | 2008-03-15 |
AU2002359891A8 (en) | 2003-07-24 |
DE60225058D1 (de) | 2008-03-27 |
US20030170768A1 (en) | 2003-09-11 |
CA2471726C (en) | 2011-04-05 |
MXPA04006367A (es) | 2005-07-13 |
DE60225058T2 (de) | 2009-10-15 |
US7374719B2 (en) | 2008-05-20 |
EP1459064A2 (de) | 2004-09-22 |
AU2002364609A1 (en) | 2003-07-24 |
EP1474692A2 (de) | 2004-11-10 |
US7494818B1 (en) | 2009-02-24 |
US7214504B2 (en) | 2007-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2471726C (en) | Test strip for determining concentration of multiple analytes in a single fluid sample | |
US8460539B2 (en) | Hybrid strip | |
AU755608B2 (en) | Visual blood glucose test strip | |
EP0654659B1 (de) | Testvorrichtung mit definiertem Volumen | |
EP0769558B1 (de) | Blutglucose-Teststreifen mit reduzierter Sensitivität für Hämatokrit | |
AU744664B2 (en) | Visually-readable reagent test strip | |
AU634339B2 (en) | Non-instrumented cholesterol assay | |
US9395373B2 (en) | Hybrid strip | |
US5326707A (en) | Composition and device for urinary protein assay and method of using the same | |
MXPA97002503A (en) | Reagent test stress to determine glucose in the san | |
AU712285B2 (en) | Direct-reading reagent test strip | |
US20040126830A1 (en) | Test strip and method for determining LDL cholesterol concentration from whole blood | |
EP2972125B1 (de) | Hybrider streifen | |
ZA200502214B (en) | Test strip and method for determining LDL cholesterol concentration from whole blood | |
JPH01107136A (ja) | 液体分析方法 | |
MXPA99007484A (en) | Stress for visual test of glucose in the san |